Stay updated on Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.
Screenshot error
Open in browserReport Problem
Clouds background image

Latest updates to the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    122 days ago
    Change Detected
    Summary
    The website has updated its contact information for study personnel, including new entries for Principal Investigators and their contact details, while removing previous listings and descriptions.
    Difference
    32%
    Check dated 2025-01-09T03:23:39.000Z thumbnail image
  2. Check
    165 days ago
    Change Detected
    Summary
    AbbVie has added a new call center and updated details for a clinical trial in Essen, Germany, while the previous entry for ImmunoGen, Inc. has been removed.
    Difference
    2%
    Check dated 2024-11-26T16:29:32.000Z thumbnail image
  3. Check
    186 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.1, replacing the previous estimated update posted in version v2.12.0.
    Difference
    0.4%
    Check dated 2024-11-05T08:55:16.000Z thumbnail image
  4. Check
    194 days ago
    Change Detected
    Summary
    The website has added a new entry for Dr. Olivia Lara, MD, who is currently suspended, and updated to version v2.12.0, while removing the entry for Dr. Linda Van Le, MD, along with her contact information.
    Difference
    0.9%
    Check dated 2024-10-29T01:36:05.000Z thumbnail image
  5. Check
    220 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-10-03T07:18:22.000Z thumbnail image
  6. Check
    227 days ago
    Change Detected
    Summary
    A new study led by Dr. Jessica Parker in Dijon, France has been added, while the previous study by Dr. Olivia Lara has been removed along with a notice about delays in displaying study records.
    Difference
    0.7%
    Check dated 2024-09-26T00:37:17.000Z thumbnail image

Stay in the know with updates to Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab vs Bevacizumab in Ovarian Cancer Clinical Trial page.